A groundbreaking approach promising to revolutionize the treatment of type 1 diabetes has emerged from the research labs of Weill Cornell Medicine. At the heart of this development is islet transplantation, which seeks to restore insulin production in patients by replacing damaged beta cells with
In the dynamic world of biopharmaceutical innovation, Ivan Kairatov stands out as an expert, particularly in the area of immunotherapy. With substantial experience in research and development, Ivan has been at the forefront of exploring the molecular intricacies of CAR-T cell therapy. This
The field of tissue engineering faces the persistent challenge of replicating the complex and diverse environments in which cells naturally exist. Traditional techniques often use gels to suspend cells between posts, easing tissue growth but complicating efforts to study how multiple tissue types
The cell and gene therapy (CGT) sector stands on the precipice of revolutionary change, reminiscent of the fast food industry’s notable standardization achievements. This provocative comparison emerged during a recent discussion at BPI Europe in Hamburg, where industry leaders delved into the
The world of gender-affirming treatments has witnessed significant advancements, yet concerns surrounding potential health risks continue to spark debates. In particular, the relationship between testosterone therapy and gynecologic cancer risks in transmasculine and gender-diverse individuals has
In recent years, the scientific community has increasingly focused on stem cell therapy as a revolutionary approach to treating neurodegenerative diseases, including dementia. As researchers delve deeper into understanding the efficacy and safety of stem cell applications, the question arises: Can
